Stepan (NYSE:SCL) Upgraded by StockNews.com to “Buy” Rating
Stepan (NYSE:SCL – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday. Stepan Price Performance Shares of SCL stock traded up $0.53 during trading hours on Friday, hitting $72.87. 155,255 shares of the company’s stock were exchanged, […]
Extreme Networks (NASDAQ:EXTR) Upgraded by StockNews.com to “Buy” Rating
Extreme Networks (NASDAQ:EXTR – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. A number of other analysts have also recently weighed in on EXTR. Craig Hallum raised their target price on shares of Extreme Networks from $17.00 to $22.50 […]
Neurocrine Biosciences (NASDAQ:NBIX) Rating Lowered to “Buy” at StockNews.com
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Friday. Other equities analysts have also issued reports about the company. Barclays reduced their price target on Neurocrine Biosciences from $180.00 to $160.00 and set an “overweight” rating […]
StockNews.com Upgrades Bio-Rad Laboratories (NYSE:BIO) to “Buy”
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. A number of other brokerages have also recently issued reports on BIO. Citigroup boosted their target price on shares of Bio-Rad Laboratories […]
YPF Sociedad Anónima (NYSE:YPF) Upgraded by StockNews.com to “Buy” Rating
YPF Sociedad Anónima (NYSE:YPF – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday. Several other research analysts have also recently commented on YPF. Bank of America boosted their price target on shares of YPF Sociedad Anónima from $28.00 to $29.00 […]
Signet Jewelers (NYSE:SIG) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Signet Jewelers (NYSE:SIG – Free Report) from a hold rating to a buy rating in a research report released on Tuesday. Other equities research analysts also recently issued reports about the company. Telsey Advisory Group reiterated a “market perform” rating and issued a $87.00 price objective on shares of Signet Jewelers […]
Neurocrine Biosciences’ (NBIX) “Buy” Rating Reaffirmed at HC Wainwright
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a note issued to investors on Friday, Benzinga reports. They currently have a $190.00 target price on the stock. HC Wainwright’s price objective suggests a potential upside of 57.98% from the company’s current price. […]
Lakeland Industries (NASDAQ:LAKE) Downgraded by StockNews.com to “Sell”
StockNews.com cut shares of Lakeland Industries (NASDAQ:LAKE – Free Report) from a hold rating to a sell rating in a report published on Tuesday morning. Separately, Roth Mkm lifted their price objective on shares of Lakeland Industries from $25.00 to $27.00 and gave the stock a “buy” rating in a research report on Wednesday, July […]
Wave Life Sciences (NASDAQ:WVE) Given “Buy” Rating at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $22.00 price target on the stock. A number of other equities research analysts have also issued reports on WVE. B. Riley increased their […]
Manitowoc (NYSE:MTW) Upgraded to Hold at StockNews.com
Manitowoc (NYSE:MTW – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Friday. MTW has been the subject of a number of other research reports. Robert W. Baird cut their price objective on shares of Manitowoc from $13.00 to $12.00 and […]
Ligand Pharmaceuticals’ (LGND) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) in a report issued on Thursday, Benzinga reports. The brokerage currently has a $157.00 target price on the biotechnology company’s stock. LGND has been the subject of a number of other reports. Oppenheimer initiated coverage on Ligand Pharmaceuticals in a […]
last updated on 2 Nov 06:30